CA
NZ
UK
AU
IND
US
Abbott Laboratories (NYSE:ABT) was up 1.29% at $91.70 as of the latest intraday update on Wednesday and was trading in territory not seen in nearly a month, as healthcare and medtech stocks attracted meaningful rotation interest from investors exiting defensive telecom and energy positions.
AbbVie Inc. (NYSE:ABBV) was down 0.43% at $233.75 as of the latest intraday update on Wednesday, as large-cap pharmaceutical names attracted less rotation interest than device and biotech peers during the broader healthcare sector's recovery.
Amgen Inc. (NASDAQ:AMGN) was up 1.48% at $352.15 as of the latest intraday update on Wednesday, as healthcare sector rotation favoured large-cap biotech names with established dividend profiles and late-stage pipeline depth, categories where Amgen holds competitive structural advantages.
As of the latest intraday update, CVS Health (NYSE:CVS) dipped less than 1% to $100.91 on Wednesday, a significantly shallower decline than early estimates suggested, as the pharmacy and health services company continues to trade near its all-time high of $103.12 following a recovery …
As of the latest intraday update, Danaher Corporation (NYSE:DHR) posted the strongest session gain among healthcare names, rising nearly 5% to $187.66, as life-science tools and diagnostics companies rebounded sharply from a prolonged drawdown driven by post-pandemic bioprocessing inventory destocking.
Treace Medical Concepts (NASDAQ:TMCI) rose 11.97% on June 23, 2026, closing at $4.49 after a $0.48 per-share move. The session’s advance came as oversold buying lifted the bunion surgery company, based on the available company disclosures and trading context.
Shuttle Pharmaceuticals (NASDAQ:SHPH) rose 9.25% on June 23, 2026, closing at $3.84 after a $0.33 per-share move. The session’s advance came as post-split trading drove a radioenhancer rebound, based on the available company disclosures and trading context.
Viking Therapeutics (NASDAQ:VKTX) rose 7.54% on June 23, 2026, closing at $34.81 after a $2.44 per-share move. The session’s advance came as new institutional coverage renewed obesity drug interest, based on the available company disclosures and trading context.
Anteris Technologies Global (NASDAQ:AVR) rose 7.19% on June 23, 2026, closing at $10.28 after a $0.69 per-share move. The session’s advance came as optimism around the Medtronic partnership supported the valve pipeline, based on the available company disclosures and trading context.
KORU Medical Systems (NASDAQ:KRMD) rose 6.99% on June 23, 2026, closing at $4.13 after a $0.27 per-share move. The session’s advance came as 22% revenue growth sustained home-infusion momentum, based on the available company disclosures and trading context.
Please wait processing your request...